A Study of Soticlestat and Rifampin in Healthy Adults
Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The main aim of this study is to check how rifampin affects the way soticlestat is processed
by the body.
Participants will be required to stay at the study clinic for 18 consecutive days. On the
first full day and 15th day, participants will take a single dose of soticlestat. Rifampin
will be taken each day starting on the 5th day for 13 consecutive days.
Clinic staff will follow up with each participant about 15 days after the last soticlestat
dose to check for any side effects.